ZA848829B - Opthalmic use of norfloxacin and related antibiotics - Google Patents

Opthalmic use of norfloxacin and related antibiotics

Info

Publication number
ZA848829B
ZA848829B ZA848829A ZA848829A ZA848829B ZA 848829 B ZA848829 B ZA 848829B ZA 848829 A ZA848829 A ZA 848829A ZA 848829 A ZA848829 A ZA 848829A ZA 848829 B ZA848829 B ZA 848829B
Authority
ZA
South Africa
Prior art keywords
norfloxacin
related antibiotics
opthalmic use
opthalmic
antibiotics
Prior art date
Application number
ZA848829A
Other languages
English (en)
Inventor
Irving M Katz
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA848829B publication Critical patent/ZA848829B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA848829A 1983-11-14 1984-11-13 Opthalmic use of norfloxacin and related antibiotics ZA848829B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/551,775 US4551456A (en) 1983-11-14 1983-11-14 Ophthalmic use of norfloxacin and related antibiotics

Publications (1)

Publication Number Publication Date
ZA848829B true ZA848829B (en) 1986-06-25

Family

ID=24202636

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA848829A ZA848829B (en) 1983-11-14 1984-11-13 Opthalmic use of norfloxacin and related antibiotics

Country Status (12)

Country Link
US (1) US4551456A (de)
EP (1) EP0142426A3 (de)
JP (1) JPS60123420A (de)
AU (1) AU567979B2 (de)
CA (1) CA1241599A (de)
DK (1) DK537784A (de)
ES (1) ES8604018A1 (de)
GR (1) GR80874B (de)
IL (1) IL73426A (de)
NZ (1) NZ210104A (de)
PT (1) PT79454B (de)
ZA (1) ZA848829B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3542972A1 (de) * 1985-12-05 1987-06-11 Merck Patent Gmbh Pharmakadepot
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
JPS635091A (ja) * 1986-06-26 1988-01-11 Senjiyu Seiyaku Kk 着色防止方法
JP2558107B2 (ja) * 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
CA1309024C (en) * 1986-12-19 1992-10-20 Hiromitsu Seki Aqueous pharmaceutical composition containing s-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl -7-oxo-2,3,-dihydro-7h-pyridol[1,2,3,-de][1,4]benzoxazine -6-carboxylic acid
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
IE873504L (en) * 1987-01-28 1988-07-28 Harvard College Stabilized ophthalmic compositions
DE3881939T2 (de) * 1987-02-26 1993-09-30 Daiichi Seiyaku Co Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne.
JPH01258620A (ja) * 1988-04-08 1989-10-16 Dai Ichi Seiyaku Co Ltd 耳疾患用局所製剤
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US5912255A (en) * 1998-02-27 1999-06-15 Bussell; Letantia Topical fluoroquinolone antibiotics combined with benzoyl peroxide
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
JP2002525326A (ja) * 1998-09-30 2002-08-13 アルコン ラボラトリーズ，インコーポレイテッド 眼、耳および鼻治療用の抗生物質組成物
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
KR20000067454A (ko) * 1999-04-28 2000-11-15 김충섭 가교형태의 실록산그룹함유 고분자분리막
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
JP2002037746A (ja) * 2000-07-24 2002-02-06 Fuji Yakuhin:Kk キノロンカルボン酸系抗菌剤を含有する液剤
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
EP2134350A1 (de) * 2007-03-14 2009-12-23 The University of Washington Vorrichtungen und verfahren für intraokulare wirkstofffreisetzung
DK2227213T3 (da) * 2007-11-30 2013-01-02 Toltec Pharmaceuticals Llc Sammensætninger og fremgangsmåder til behandling af vaginale infektioner og patogene, vaginle biofilm
JP2011520963A (ja) * 2008-05-19 2011-07-21 アルコン リサーチ， リミテッド カルボキシビニルポリマーおよびポビドンポリマーを有する医薬組成物
CN105534886A (zh) * 2015-12-31 2016-05-04 湖北远大天天明制药有限公司 一种诺氟沙星滴眼剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
GB1598915A (en) * 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IE52125B1 (en) * 1980-10-02 1987-06-24 Fox Charles L Jun 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy

Also Published As

Publication number Publication date
JPS60123420A (ja) 1985-07-02
DK537784A (da) 1985-05-15
ES8604018A1 (es) 1986-01-16
IL73426A0 (en) 1985-02-28
IL73426A (en) 1989-03-31
AU3538084A (en) 1985-05-23
PT79454B (en) 1986-12-11
ES537584A0 (es) 1986-01-16
EP0142426A2 (de) 1985-05-22
US4551456A (en) 1985-11-05
GR80874B (en) 1985-03-07
NZ210104A (en) 1988-03-30
CA1241599A (en) 1988-09-06
AU567979B2 (en) 1987-12-10
PT79454A (en) 1984-12-01
EP0142426A3 (de) 1986-12-17
DK537784D0 (da) 1984-11-13

Similar Documents

Publication Publication Date Title
ZA848829B (en) Opthalmic use of norfloxacin and related antibiotics
GB2145422B (en) Novel poly-esters their preparation and pharmacolgical use thereof
AU564963B2 (en) N-alkoxyaminosulfonyl-ureas and n-alkyl- sulfonylaminosulfonylureas
DE3477935D1 (en) An immoblized lipase preparation and use thereof
AU588220B2 (en) Improved expression vector and use thereof
DE3262017D1 (en) Sterile dressing and preparation thereof
NZ210135A (en) 2-pyridylmethyl-thio and sulphinyl-benzimidazole derivatives
HK50093A (en) The aglycone and pseudo-aglycones of the aad216 antibiotics
GB8330137D0 (en) Treatment of glass
ZA842431B (en) Novel anilines and their use
AU8427091A (en) Gamma-carboxylase and methods of use
AU576717B2 (en) N6 - bicycloadenosines and methods of use
AU569529B2 (en) Rooperol and derivatives
DE3471652D1 (en) Diurethane-diureas and use
GB2169508B (en) Ophthalmic compositions and use
GB8333624D0 (en) Antibiotics l 17054 and l 17392
GB8422542D0 (en) Naphthalenylimidazopyridine and derivatives
AU3601684A (en) Pyrid-4-one and quinilone derivatives
AU573272B2 (en) Dihydroisoquinolines and tetrahydroisoquinolones
PT78937B (en) Assignlent and agreement
PH21682A (en) Dihydroindenothiadiazinone and dihydronaphthothiadiazinone derivatives
JPS6450846A (en) Arylbisperfluoroalkylcarbinol and manufacture of same
GB8323796D0 (en) Preparation of haloacetals and halodioxolanes
GR80455B (en) 3-azidocephalosporins as intremediates and novel antibacterial agents
EP0134546A3 (en) Novel strains and use thereof